EMIS Group (EMIS) Half-year results presentation 2021

Emis’s CEO, Andy Thornburn and CFO, Peter Southby present interim results for the six months ended 30 June 2021. Revenue and adjusted operating profit were ahead of both H1 20 and 19. Recurring revenue represents 79%. The dividend has grown to 10%. EMIS Enterprise was boosted by the use of the Outcomes4Health solution to support the CV19 roll-out in England. EMIS-X development continues and is building strong foundations for future growth. The outlook is in line with expectations for the full year.

Andy Thorburn, CEO
00:17 Introduction

Peter Southby, CFO
01:00 Financial highlights
02:43 Income statement
04:10 Segmental analysis
05:13 Revenue analysis
06:26 Cash flow
07:43 Balance sheet
08:21 Guidance and trends

Andy Thorburn, CEO
10:00 Operational review
11:17 H1 positive progress
14:50 Healthcare market evolution
18:00 Accelerating growth over the coming years
28:49 Market positioning and capabilities
29:55 Outlook

EMIS Group plc provides healthcare software, information technology and related services in the United Kingdom. The Company’s segments include Primary & Community Care and Community Pharmacy. The Company serves various healthcare markets under the EMIS Health brand. The Primary & Community Care division provides clinical information technology (IT) systems for general practitioners (GPs) and commissioners. The Community Pharmacy division is an integrated community pharmacy dispensary and retail system. EMIS Health provides clinical software to customers across the healthcare sector. Its brand EMIS Care specializes in the delivery of diabetic retinopathy eye screening.